[Serological demonstration of individual-specific tissue antibodies; relation to the problem of organ transplantation].

PubWeight™: 0.77‹?›

🔗 View Article (PMID 13351567)

Published in Schweiz Med Wochenschr on June 09, 1956

Authors

W BOLLAG

Articles by these authors

The degradation of deoxyribonucleic acid by new tumour inhibiting compounds: the intermediate formation of hydrogen peroxide. Experientia (1963) 1.10

[The effect of myleran on the germ cells of rats]. Experientia (1953) 0.96

[Cystostatica in pregnancy]. Schweiz Med Wochenschr (1954) 0.86

NEW DEVELOPMENTS IN CANCER RESEARCH. CHEMOTHERAPY OF CANCER: REPORT ON THE LUGANO SYMPOSIUM. Experientia (1965) 0.86

Cytological investigations with a new class of cytotoxic agents. methylhydrazine derivatives. Experientia (1963) 0.85

[Myleran, a new cytostatic drug in leukemias]. Schweiz Med Wochenschr (1953) 0.85

[Heterologous transplantation of tumors in pretreatment of the recipient animals with tissue from donor animals during embryonic period]. Experientia (1955) 0.81

The effect of DL-ethionine on the content of some enzymes in pancreas and liver. Biochim Biophys Acta (1952) 0.81

Suppression of the immunological reaction by methylhydrazines, a new class of antitumour agents. Experientia (1963) 0.81

Tumour inhibitory effects of a new class of cytotoxic agents: methylhydrazine derivatives. Experientia (1963) 0.80

PRELIMINARY CLINICAL RESULTS WITH A NEW ANTITUMOR AGENT RO 4-6467 (NSC-77213). Cancer Chemother Rep (1963) 0.77

[Determination of organ specific antibodies]. Experientia (1956) 0.77

[Heterologous transplantation of tumors after pretreatment of host animals with radioactive isotopes]. Experientia (1954) 0.76

[Not Available]. Oncologia (1956) 0.75

[Heterologous transplantation of tumors]. Oncologia (1954) 0.75

[Experience with actinomycin C]. Schweiz Med Wochenschr (1954) 0.75

THE TUMOR-INHIBITORY EFFECTS OF THE METHYLHYDRAZINE DERIVATIVE RO 4-6467/1 (NSC-77213). Cancer Chemother Rep (1963) 0.75

[Heterologous transplantation of tumors after preliminary treatment of tumor-bearing animals with radioisotopes]. Oncologia (1955) 0.75

[Detection of individual-specific tissue antibodies]. Experientia (1956) 0.75

[Not Available]. Oncologia (1955) 0.75

[1st clinical experiences with a new cytostatic]. Schweiz Med Wochenschr (1963) 0.75

[Experimental studies on the effect of some cytostatics on the blood picture]. Schweiz Med Wochenschr (1953) 0.75

[Active and passive immunity against heterologous tumors]. Experientia (1955) 0.75

[The effect of patulin on the myelo- and lymphopoietic system of the mouse]. Experientia (1949) 0.75

[Experimental kidney damage with methyl-tryptophan]. Virchows Arch (1953) 0.75

[Experimental studies on 5-fluorouracil, a cytostatic agent]. Schweiz Med Wochenschr (1957) 0.75

[Influence of thiosemicarbazone on erythrocyte sedimentation]. Dtsch Med Wochenschr (1951) 0.75